Intra Cellular Therapies | Attività Correnti

Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
Cytokinetics USD 628.05M 66.63M 2023-12
Gilead Sciences USD 16.45B 474M 2023-12
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Intra Cellular Therapies USD 667.8M 34.63M 2023-12
RedHill Biopharma USD 27.05M 19.47M 2023-06
Supernus Pharmaceuticals USD 493.11M 43.75M 2023-12



Intra Cellular Therapies Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.